Dr Boeldridge Mcclain, MD - Medicare Anesthesiology in Surprise, AZ

Dr Boeldridge Mcclain, MD is a medicare enrolled "Anesthesiology" physician in Surprise, Arizona. He went to Medical College Of Wisconsin and graduated in 1999 and has 25 years of diverse experience with area of expertise as Anesthesiology. He is a member of the group practice Grand Canyon Anesthesia Llc and his current practice location is 12361 W Bola Dr Ste 107, Surprise, Arizona. You can reach out to his office (for appointments etc.) via phone at (623) 974-9571.

Dr Boeldridge Mcclain is licensed to practice in Arizona (license number 30909) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1992772446.

Contact Information

Dr Boeldridge Mcclain, MD
12361 W Bola Dr Ste 107,
Surprise, AZ 85378-9021
(623) 974-9571
(623) 974-9741



Physician's Profile

Full NameDr Boeldridge Mcclain
GenderMale
SpecialityAnesthesiology
Experience25 Years
Location12361 W Bola Dr Ste 107, Surprise, Arizona
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Boeldridge Mcclain attended and graduated from Medical College Of Wisconsin in 1999
  NPI Data:
  • NPI Number: 1992772446
  • Provider Enumeration Date: 03/03/2006
  • Last Update Date: 07/21/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 9234020413
  • Enrollment ID: I20040324001572

Medical Identifiers

Medical identifiers for Dr Boeldridge Mcclain such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1992772446NPI-NPPES
920703MedicaidAZ

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207L00000XAnesthesiology 4301093420 (Michigan)Secondary
207L00000XAnesthesiology 44175 (Wisconsin)Secondary
207L00000XAnesthesiology ME102957 (Florida)Secondary
207L00000XAnesthesiology 061624 (Georgia)Secondary
207LP2900XAnesthesiology - Pain Medicine 30909 (Arizona)Secondary
208VP0000XPain Medicine - Pain Medicine 30909 (Arizona)Secondary
207L00000XAnesthesiology 30909 (Arizona)Primary
207L00000XAnesthesiology 14954 (Hawaii)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Western Regional Medical CenterGoodyear, AZHospital
Arizona Orthopedic And Surgical Specialty HospitalChandler, AZHospital
Core Institute Specialty Hospital, ThePhoenix, AZHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Grand Canyon Anesthesia Llc367882475231

News Archive

Bioengineers receive $2 million NIH grant to develop new toxicology tests

Chemicals in pharmaceutical drugs can obviously save lives. But as more and stronger chemicals have been introduced, our basic knowledge of the broader health impact of all these chemicals has not kept up with the rapid pace of innovation. There is exceptionally little information on how chemicals in our drugs and also in the environment around us, including on the food we eat, impact some of the most important cells in our body: stem cells. Without basic knowledge and tests on the impact of chemicals on our stem cells, we may be unwittingly damaging essential regenerative functions in our body.

Epizyme raises $32 million through its Series B financing

Epizyme, Inc., a biopharmaceutical company translating key discoveries in the field of epigenetics into novel pharmaceutical agents, announced today the closing of a $32 million Series B financing led by new investor Bay City Capital (BCC).

Drug company proposes FDA check all drug advertising prior to marketing

Drug company AstraZeneca has proposed that it should be a mandatory requirement for pharmaceutical companies to submit all direct-to-consumer advertising to the U.S. Food and Drug Administration for review prior to its use.

$100m needed to stop spread of birdflu

In an effort to contain the spread of bird flu, one of the UN agencies' focuses is live food markets, and the World Health Organization (WHO) is calling for a reform of farming and food production methods to contain the spread of the virus.

New educational resource to help improve knowledge, treatment of Inflammatory Bowel Disease

A new educational resource for doctors and healthcare professionals will help improve knowledge and treatment of Inflammatory Bowel Disease (IBD). The Inflammatory Bowel Disease Resource Centre was developed by Elsevier, the journal Digestive and Liver Disease, and was made possible through an educational grant from Ferring Pharmaceuticals.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Boeldridge Mcclain allows following entities to bill medicare on his behalf.
Entity NameBanner Hospital Based Physicians Arizona Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1275889891
PECOS PAC ID: 3274782487
Enrollment ID: O20121003000752

News Archive

Bioengineers receive $2 million NIH grant to develop new toxicology tests

Chemicals in pharmaceutical drugs can obviously save lives. But as more and stronger chemicals have been introduced, our basic knowledge of the broader health impact of all these chemicals has not kept up with the rapid pace of innovation. There is exceptionally little information on how chemicals in our drugs and also in the environment around us, including on the food we eat, impact some of the most important cells in our body: stem cells. Without basic knowledge and tests on the impact of chemicals on our stem cells, we may be unwittingly damaging essential regenerative functions in our body.

Epizyme raises $32 million through its Series B financing

Epizyme, Inc., a biopharmaceutical company translating key discoveries in the field of epigenetics into novel pharmaceutical agents, announced today the closing of a $32 million Series B financing led by new investor Bay City Capital (BCC).

Drug company proposes FDA check all drug advertising prior to marketing

Drug company AstraZeneca has proposed that it should be a mandatory requirement for pharmaceutical companies to submit all direct-to-consumer advertising to the U.S. Food and Drug Administration for review prior to its use.

$100m needed to stop spread of birdflu

In an effort to contain the spread of bird flu, one of the UN agencies' focuses is live food markets, and the World Health Organization (WHO) is calling for a reform of farming and food production methods to contain the spread of the virus.

New educational resource to help improve knowledge, treatment of Inflammatory Bowel Disease

A new educational resource for doctors and healthcare professionals will help improve knowledge and treatment of Inflammatory Bowel Disease (IBD). The Inflammatory Bowel Disease Resource Centre was developed by Elsevier, the journal Digestive and Liver Disease, and was made possible through an educational grant from Ferring Pharmaceuticals.

Read more Medical News

› Verified 3 days ago

Entity NameGrand Canyon Anesthesia Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1356822902
PECOS PAC ID: 3678824752
Enrollment ID: O20180928002378

News Archive

Bioengineers receive $2 million NIH grant to develop new toxicology tests

Chemicals in pharmaceutical drugs can obviously save lives. But as more and stronger chemicals have been introduced, our basic knowledge of the broader health impact of all these chemicals has not kept up with the rapid pace of innovation. There is exceptionally little information on how chemicals in our drugs and also in the environment around us, including on the food we eat, impact some of the most important cells in our body: stem cells. Without basic knowledge and tests on the impact of chemicals on our stem cells, we may be unwittingly damaging essential regenerative functions in our body.

Epizyme raises $32 million through its Series B financing

Epizyme, Inc., a biopharmaceutical company translating key discoveries in the field of epigenetics into novel pharmaceutical agents, announced today the closing of a $32 million Series B financing led by new investor Bay City Capital (BCC).

Drug company proposes FDA check all drug advertising prior to marketing

Drug company AstraZeneca has proposed that it should be a mandatory requirement for pharmaceutical companies to submit all direct-to-consumer advertising to the U.S. Food and Drug Administration for review prior to its use.

$100m needed to stop spread of birdflu

In an effort to contain the spread of bird flu, one of the UN agencies' focuses is live food markets, and the World Health Organization (WHO) is calling for a reform of farming and food production methods to contain the spread of the virus.

New educational resource to help improve knowledge, treatment of Inflammatory Bowel Disease

A new educational resource for doctors and healthcare professionals will help improve knowledge and treatment of Inflammatory Bowel Disease (IBD). The Inflammatory Bowel Disease Resource Centre was developed by Elsevier, the journal Digestive and Liver Disease, and was made possible through an educational grant from Ferring Pharmaceuticals.

Read more Medical News

› Verified 3 days ago

Entity NameAnesthesia Partners Of Arizona Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1619452901
PECOS PAC ID: 8628317179
Enrollment ID: O20190228001927

News Archive

Bioengineers receive $2 million NIH grant to develop new toxicology tests

Chemicals in pharmaceutical drugs can obviously save lives. But as more and stronger chemicals have been introduced, our basic knowledge of the broader health impact of all these chemicals has not kept up with the rapid pace of innovation. There is exceptionally little information on how chemicals in our drugs and also in the environment around us, including on the food we eat, impact some of the most important cells in our body: stem cells. Without basic knowledge and tests on the impact of chemicals on our stem cells, we may be unwittingly damaging essential regenerative functions in our body.

Epizyme raises $32 million through its Series B financing

Epizyme, Inc., a biopharmaceutical company translating key discoveries in the field of epigenetics into novel pharmaceutical agents, announced today the closing of a $32 million Series B financing led by new investor Bay City Capital (BCC).

Drug company proposes FDA check all drug advertising prior to marketing

Drug company AstraZeneca has proposed that it should be a mandatory requirement for pharmaceutical companies to submit all direct-to-consumer advertising to the U.S. Food and Drug Administration for review prior to its use.

$100m needed to stop spread of birdflu

In an effort to contain the spread of bird flu, one of the UN agencies' focuses is live food markets, and the World Health Organization (WHO) is calling for a reform of farming and food production methods to contain the spread of the virus.

New educational resource to help improve knowledge, treatment of Inflammatory Bowel Disease

A new educational resource for doctors and healthcare professionals will help improve knowledge and treatment of Inflammatory Bowel Disease (IBD). The Inflammatory Bowel Disease Resource Centre was developed by Elsevier, the journal Digestive and Liver Disease, and was made possible through an educational grant from Ferring Pharmaceuticals.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Boeldridge Mcclain is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Boeldridge Mcclain, MD
12361 W Bola Dr Ste 107,
Surprise, AZ 85378-9021

Ph: (623) 974-9571
Dr Boeldridge Mcclain, MD
12361 W Bola Dr Ste 107,
Surprise, AZ 85378-9021

Ph: (623) 974-9571

News Archive

Bioengineers receive $2 million NIH grant to develop new toxicology tests

Chemicals in pharmaceutical drugs can obviously save lives. But as more and stronger chemicals have been introduced, our basic knowledge of the broader health impact of all these chemicals has not kept up with the rapid pace of innovation. There is exceptionally little information on how chemicals in our drugs and also in the environment around us, including on the food we eat, impact some of the most important cells in our body: stem cells. Without basic knowledge and tests on the impact of chemicals on our stem cells, we may be unwittingly damaging essential regenerative functions in our body.

Epizyme raises $32 million through its Series B financing

Epizyme, Inc., a biopharmaceutical company translating key discoveries in the field of epigenetics into novel pharmaceutical agents, announced today the closing of a $32 million Series B financing led by new investor Bay City Capital (BCC).

Drug company proposes FDA check all drug advertising prior to marketing

Drug company AstraZeneca has proposed that it should be a mandatory requirement for pharmaceutical companies to submit all direct-to-consumer advertising to the U.S. Food and Drug Administration for review prior to its use.

$100m needed to stop spread of birdflu

In an effort to contain the spread of bird flu, one of the UN agencies' focuses is live food markets, and the World Health Organization (WHO) is calling for a reform of farming and food production methods to contain the spread of the virus.

New educational resource to help improve knowledge, treatment of Inflammatory Bowel Disease

A new educational resource for doctors and healthcare professionals will help improve knowledge and treatment of Inflammatory Bowel Disease (IBD). The Inflammatory Bowel Disease Resource Centre was developed by Elsevier, the journal Digestive and Liver Disease, and was made possible through an educational grant from Ferring Pharmaceuticals.

Read more News

› Verified 3 days ago


Anesthesiology Doctors in Surprise, AZ

Gary Wayne Bowman, M.D.
Anesthesiology
Medicare: Not Enrolled in Medicare
Practice Location: 16501 N El Mirage Rd, 240, Surprise, AZ 85378
Phone: 469-964-1960    
Dr. Thinh K Le, MD
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 12361 W Bola Dr Ste 109, Surprise, AZ 85374
Phone: 623-332-1441    Fax: 602-237-5238

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.